New York State Common Retirement Fund
ARIA

New York State Common Retirement Fund’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

New York State Common Retirement Fund’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-181,200
Closed -$2.25M – 3189
2016
Q4 		$2.25M Sell
181,200
-21,470
-11% -$259K ﹤0.01% 1629
2016
Q3 		$2.77M Buy
202,670
+21,470
+12% +$216K ﹤0.01% 1506
2016
Q2 		$1.34M Buy
181,200
+17,500
+11% +$131K ﹤0.01% 1823
2016
Q1 		$1.05M Sell
163,700
-29,480
-15% -$165K ﹤0.01% 1918
2015
Q4 		$1.21M Buy
193,180
+29,480
+18% +$193K ﹤0.01% 1867
2015
Q3 		$956K Sell
163,700
-9,935
-6% -$76.5K ﹤0.01% 1976
2015
Q2 		$1.44M Buy
173,635
+95,800
+123% +$847K ﹤0.01% 2001
2015
Q1 		$641K Buy
+77,835
New +$575K ﹤0.01% 1980
2013
Q4 		– Sell
-74,744
Closed -$1.38M – 1984
2013
Q3 		$1.38M Buy
74,744
+71,144
+1,976% +$1.38M ﹤0.01% 1677
2013
Q2 		$63K Buy
+3,600
New +$63.8K ﹤0.01% 1813

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

New York State Common Retirement Fund's ARIA Position: Q1 2017 in Review

New York State Common Retirement Fund sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 181,200 shares — an estimated $2.25M sold.

New York State Common Retirement Fund first reported a position in ARIA in Q2 2013 and held it in 10 quarters. The position peaked at $2.77M in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • New York State Common Retirement Fund reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • New York State Common Retirement Fund sold 181,200 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $2.25M.
  • New York State Common Retirement Fund first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 10 quarters.
  • New York State Common Retirement Fund's Ariad Pharmaceuticals Inc position peaked at $2.77M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on New York State Common Retirement Fund's 13F filing for Q1 2017, filed 15 May 2017.